The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Peter M. Anderson

Division of Pediatrics

University of Texas MD Anderson Cancer Center

Houston

Texas 77030-4009

USA

[email]@mdanderson.org

Name/email consistency: high

[Claim this account]

Affiliations

Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA. 2010
University of Texas, MD Anderson Cancer Center, Dept. of Pediatrics, Houston, USA. 2007 - 2010

References

Continuously improving ifosfamide/mesna: a winning combination. Anderson, P. Pediatr. Blood. Cancer (2010) [Pubmed]
Mifamurtide in osteosarcoma--a practical review. Anderson, P.M., Tomaras, M., McConnell, K. Drugs. Today (2010) [Pubmed]
Non-Surgical Treatment of Pulmonary and Extra-pulmonary Metastases. Anderson, P. Cancer Treat. Res. (2010) [Pubmed]
The therapeutic alliance: adapting to the unthinkable with better information. Anderson, P., Kaye, L. Health. Commun (2009) [Pubmed]
Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma). Anderson, P., Kopp, L., Anderson, N., Cornelius, K., Herzog, C., Hughes, D., Huh, W. Expert. Opin. Investig. Drugs (2008) [Pubmed]
Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Anderson, P., Aguilera, D., Pearson, M., Woo, S. Cancer. Control (2008) [Pubmed]
Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma. Anderson, P., Nuñez, R. Expert. Rev. Anticancer. Ther (2007) [Pubmed]
Chemotherapy for osteosarcoma with high-dose methotrexate is effective and outpatient therapy is now possible. Anderson, P. Nat. Clin. Pract. Oncol (2007) [Pubmed]
Osteosarcoma relapse: expect the worst, but hope for the best. Anderson, P. Pediatr. Blood. Cancer (2006) [Pubmed]
Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma. Anderson, P. Future. Oncology. (london,. England) (2006) [Pubmed]
Samarium for osteoblastic bone metastases and osteosarcoma. Anderson, P. Expert. Opin. Pharmacother (2006) [Pubmed]
Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives. Anderson, P., Salazar-Abshire, M. Curr. Oncol. Rep (2006) [Pubmed]
Novel therapeutic approaches in pediatric and young adult sarcomas. Anderson, P.M., Pearson, M. Curr. Oncol. Rep (2006) [Pubmed]
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Anderson, P.M., Wiseman, G.A., Erlandson, L., Rodriguez, V., Trotz, B., Dubansky, S.A., Albritton, K. Clin. Cancer Res. (2005) [Pubmed]